Hepatitis B surface antigen detection using pooled sera. A cost-benefit analysis.
OBJECTIVE
To examine the feasibility and to perform a cost benefit analysis of a 5-sample pooling strategy using an enzyme immunoassay (EIA) for the screening of hepatitis B surface antigen (HBsAg).


METHODS
To assess the sensitivity and specificity of the pooling method, each of the 40 positive sera (from weak to intensely HBsAg-positive) and 250 negative sera were tested in a pool with 4 HBsAg-negative sera. The limit of detection for HBsAg/ad and HBsAg/ay was evaluated using sera from a panel of purified subtypes. A study under real conditions was conducted using pools from 340 pregnant women.


RESULTS
The sensitivity and specificity of this technique were 100%. The correlation coefficient among the sample/cutoff ratios of 40 samples studied in single and in pooled conditions was 0.792 (p < 0.005). The pooling method has lower levels of detection for HBsAg/ad and HBsAg/ay at 0.20 ng/mL and 0.12 ng/mL, and the single method at 0.34 ng/mL and 0.29 ng/mL, respectively. The pooling method loses no sensitivity for values up to 100 IU/L of anti-HBs in the four sera mixed with a positive serum. The cost-benefit analysis showed that the pooling method could save from 30% up to 75% of the cost of HBsAg determination, according to whether seroprevalences were 10% or 1%, respectively.


CONCLUSIONS
The pooled HBsAg EIA yielded no worse than the single EIA test, and was a cost-effective and valid strategy in areas with a high, medium or low prevalence.
Fernández
E
E
Service of Biochemistry, Hospital de Cabueñes, Gijón, Spain.
Rodrigo
L
L
García
S
S
Riestra
S
S
Blanco
C
C
D001800:Blood Specimen Collection / Q000191:economics; D002353:Carrier State / Q000097:blood / Q000175:diagnosis*; D003362:Cost-Benefit Analysis; D006509:Hepatitis B / Q000097:blood / Q000175:diagnosis*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D007124:Immunoenzyme Techniques / Q000191:economics; D008403:Mass Screening / Q000191:economics / Q000379:methods*; D012680:Sensitivity and Specificity; D013030:Spain
D006514:Hepatitis B Surface Antigens